129 related articles for article (PubMed ID: 29069850)
1. Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis.
Xie W; Li T; Yang J; Shang M; Xiao Y; Li Q; Yang J
Oncotarget; 2017 Sep; 8(42):73079-73086. PubMed ID: 29069850
[TBL] [Abstract][Full Text] [Related]
2. Metformin and endometrial cancer survival: a quantitative synthesis of observational studies.
Guo J; Xu K; An M; Zhao Y
Oncotarget; 2017 Sep; 8(39):66169-66177. PubMed ID: 29029501
[TBL] [Abstract][Full Text] [Related]
3. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of metformin treatment in endometrial cancer: a meta-analysis.
Gong H; Chen Y; Zhou D
Pharmazie; 2020 Aug; 75(8):401-406. PubMed ID: 32758341
[No Abstract] [Full Text] [Related]
5. Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis.
Wan G; Sun X; Li F; Wang X; Li C; Li H; Yu X; Cao F
Cell Physiol Biochem; 2018; 49(3):837-847. PubMed ID: 30184547
[TBL] [Abstract][Full Text] [Related]
6. Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis.
Nayan M; Punjani N; Juurlink DN; Finelli A; Austin PC; Kulkarni GS; Uleryk E; Hamilton RJ
Am J Clin Oncol; 2019 Mar; 42(3):275-284. PubMed ID: 30663998
[TBL] [Abstract][Full Text] [Related]
7. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
Xie H; Li M; Zheng Y
Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
[TBL] [Abstract][Full Text] [Related]
8. Effects of metformin on endometrial cancer: Systematic review and meta-analysis.
Meireles CG; Pereira SA; Valadares LP; RĂªgo DF; Simeoni LA; Guerra ENS; Lofrano-Porto A
Gynecol Oncol; 2017 Oct; 147(1):167-180. PubMed ID: 28760367
[TBL] [Abstract][Full Text] [Related]
9. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis.
Tian S; Lei HB; Liu YL; Chen Y; Dong WG
Chronic Dis Transl Med; 2017 Sep; 3(3):169-175. PubMed ID: 29063073
[TBL] [Abstract][Full Text] [Related]
10. Metformin use and survival of lung cancer patients: Meta-analysis findings.
Zhong S; Wu Y; Yan X; Tang J; Zhao J
Indian J Cancer; 2017; 54(1):63-67. PubMed ID: 29199666
[TBL] [Abstract][Full Text] [Related]
11. The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis.
Li X; Li T; Liu Z; Gou S; Wang C
Sci Rep; 2017 Jul; 7(1):5825. PubMed ID: 28724893
[TBL] [Abstract][Full Text] [Related]
12. No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies.
Wang Y; Liu X; Yan P; Bi Y; Liu Y; Zhang ZJ
Curr Pharm Des; 2019; 25(23):2595-2601. PubMed ID: 31333095
[TBL] [Abstract][Full Text] [Related]
13. Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis.
Xu H; Chen K; Jia X; Tian Y; Dai Y; Li D; Xie J; Tao M; Mao Y
Oncologist; 2015 Nov; 20(11):1236-44. PubMed ID: 26446233
[TBL] [Abstract][Full Text] [Related]
14. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
[TBL] [Abstract][Full Text] [Related]
15. Metformin and prostate cancer mortality: a meta-analysis.
Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL
Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of anti-diabetic medications in pancreatic cancer: A meta-analysis.
Zhou DC; Gong H; Tan CQ; Luo JQ
Oncotarget; 2017 Sep; 8(37):62349-62357. PubMed ID: 28977950
[TBL] [Abstract][Full Text] [Related]
17. The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis.
Xiao Y; Zheng L; Mei Z; Xu C; Liu C; Chu X; Hao B
Oncotarget; 2017 Nov; 8(59):100449-100458. PubMed ID: 29245991
[TBL] [Abstract][Full Text] [Related]
18. Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis.
Chu D; Wu J; Wang K; Zhao M; Wang C; Li L; Guo R
BMC Cancer; 2018 Apr; 18(1):438. PubMed ID: 29669520
[TBL] [Abstract][Full Text] [Related]
19. Metformin has no Significant Anticancer Effect on Patients with Advanced or Unresectable Cancer: A Systematic Review and Meta-analysis.
Gan X; Cao C; He Y; Hu X; Peng X; Su Y
Curr Pharm Des; 2022; 28(16):1351-1358. PubMed ID: 35352646
[TBL] [Abstract][Full Text] [Related]
20. The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.
Wang Y; Fu T; Liu Y; Yang G; Yu C; Zhang ZJ
Curr Pharm Des; 2020; 26(26):3161-3170. PubMed ID: 32067604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]